About Yishan Li
Yishan Li is an executive chairman at BlossomHill Therapeutics.
Yishan Li reports to the SEC as a director, officer or major shareholder of 2 public companies, including Turning Point Therapeutics (TPTX).
Yishan Li first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Yishan Li in the role, so the role may have started earlier or lasted longer.
TI
Turning Point Therapeutics, Inc.
Director and 10% owner
2019 · Public company (TPTX)
Key Colleagues at Startups
The people Yishan Li works with at each company, as listed on that company's latest Form D.
BlossomHill Therapeutics, Inc. · Form D, Dec 10, 2025
GL
George Lee
Director
CG
Carl Gordon
Director
SA
Sundeep Agrawal
Director
BC
Bihua Chen
Director
TS
Timothy Stubbs
Director
JC
Jingrong Jean Cui
President and Chief Executive Officer, director